Having committed to a fast rollout of APIs at the start of the summer, the FDA made good on its promise this week by making data on drug labeling available. And the regulator went beyond its initial commitment by releasing an API for medical device adverse events.
The first batch of Y Combinator-backed life science companies made their pitches at the incubator's Demo Day this week. And with one of the startups already bagging $4.5 million from angel investors, Y Combinator is optimistic it can continue to expand into healthcare.
Clinverse and Comprehend have raised a total of $30.1 million in separate Series C and B financing rounds, giving both companies the cash to push ahead with their expansion plans.
Digital health investor Rock Health has added 8 startups to its portfolio, bringing the number of active companies in its network up to 55. And with one of the startups focusing on life science R&D and Abbott among its new corporate partners, the incubator has strengthened its ties to drug development.
With scholarly social network ResearchGate now adding 10,000 users a day to its network of 4.5 million researchers, the idea of a "Facebook for science" has finally taken off. But these numbers say nothing about whether people actually use the site and why, a shortcoming Nature has tried to fix by surveying thousands of researchers about their social media habits.
With Oxford Nanopore's oversubscribed offering pulling in $59 million (£35 million), the British startup has the money to scale up production of its sequencer while developing new uses for the underlying technology.
Intel has spent the past year adding tools for gathering and analyzing data, notably by taking a stake in Cloudera and buying Basis. And the strategy now has a major test case, with the Michael J. Fox Foundation teaming up with Intel to remotely monitor people with Parkinson's disease.
Big Data nonprofit Bayes Impact has teamed up with 5 U.S. universities to give students a chance to use their analytics capabilities to address social problems, VentureBeat reports.
Less than one year has passed since a $760,000, Mark Cuban-backed seed round put Validic on the map, but the firm and its health data aggregation platform have come a long way in the intervening months. And with Validic's scale and ambition growing, the company has raised $5 million in first round funding.
Pfizer and 23andMe have teamed up to identify genetic factors linked to inflammatory bowel disease. And with 23andMe trumpeting the fact that people can participate without leaving their homes, the study represents a continuation of Pfizer's interest in virtual trials.
The website for Google's antiaging startup Calico has gone live, but details of the venture remain scarce.
While early adopters of Illumina's $1,000 genome machine the HiSeq X Ten have been testing the system for months, researchers from less wealthy organizations have had no access to the technology. In a limited way that changed this week, when the Garvan Institute of Medical Research, DNAnexus and AllSeq teamed up to share data from a HiSeq X Ten.
Over the past year, many tech heavyweights have begun moving into the mHealth sector. Developers got an early look at Google's offering this week, with the search giant releasing a preview version of its APIs for health app developers.
Over the past year a clutch of startups have talked up their ability to automate aspects of R&D by matching software to robotic technologies. But the ambitions of some groups go well beyond these examples, with researchers aiming to create robo-chemists.
Amid all the controversies generated by the big neuroscience initiatives getting underway on either side of the Atlantic, areas of common ground such as the need to standardize and share data have emerged. Now, a group of U.S. research institutions have teamed up to establish a unified data format to facilitate the sharing of information.
PatientsLikeMe is continuing to expand its business into new areas. Having struck its first broad R&D collaboration with a biopharma earlier this year, the online patient network has now given Actelion access to its community to create a new health outcome measure for a rare cancer.
With some biopharma still wary of moving their data into the cloud and the rest seeking vendors with solid cybersecurity credentials, Medidata has tapped Sumo Logic and The Herjavec Group (THG) to bolster its defenses. The new system uses machine-learning algorithms to identify threats.
Venter has gone to Mountain View to make his latest hire, nabbing Franz Och to build a Google Translate for genomics.
The challenge calls on competitors to create the most accurate algorithms for detecting Single Nucleotide Variants (SNVs) and Structural Variations (SVs).
While Google-backed personal genetics startup 23andMe is still working through its disagreements with the FDA, the company has impressed another part of the federal machine enough to win funding.